Therapeutic strategies in congestive heart failure and the new inotrope-vasodilator agents.
作者信息
Simonton C A
出版信息
West J Med. 1985 Feb;142(2):235-44.
Abstract
摘要
相似文献
1
Therapeutic strategies in congestive heart failure and the new inotrope-vasodilator agents.充血性心力衰竭的治疗策略与新型强心-血管扩张剂
West J Med. 1985 Feb;142(2):235-44.
2
3
Therapeutic approach to the failing heart.对衰竭心脏的治疗方法。
Pediatr Ann. 1985 Apr;14(4):304, 307-8, 310-11. doi: 10.3928/0090-4481-19850401-08.
4
[Treatment of heart failure: what--when--how?].[心力衰竭的治疗：什么——何时——如何？]
Verh Dtsch Ges Inn Med. 1990;96:157-67.
5
[Therapy of heart failure].
Clin Ter. 1987 Feb 15;120(3):237-46.
6
The role of vasodilators in managing congestive heart failure.血管扩张剂在治疗充血性心力衰竭中的作用。
Postgrad Med. 1980 Jan;67(1):87-91, 94-8. doi: 10.1080/00325481.1980.11715340.
7
[Cardiac insufficiency in childhood].[儿童期心脏功能不全]
Arq Bras Cardiol. 1979 Nov;33(5):359-68.
8
Modern treatment of heart failure.心力衰竭的现代治疗
BMJ. 1988 Jul 9;297(6641):83-4. doi: 10.1136/bmj.297.6641.83.
9
[Pharmacologic treatment of heart failure: general principle].
Nihon Rinsho. 2007 May 28;65 Suppl 5:7-13.
10
The management of congestive heart failure.充血性心力衰竭的管理
Curr Probl Cardiol. 1984 Feb;8(11):1-70. doi: 10.1016/0146-2806(84)90019-7.
本文引用的文献
1
DIGITALIS IN HEART FAILURE WITH NORMAL RHYTHM.正常节律性心力衰竭中的洋地黄
Br Heart J. 1939 Jan;1(1):27-44. doi: 10.1136/hrt.1.1.27.
2
DIGITALIS AND DIURETICS IN HEART FAILURE WITH REGULAR RHYTHM, WITH ESPECIAL REFERENCE TO THE IMPORTANCE OF ETIOLOGIC CLASSIFICATION OF HEART DISEASE.洋地黄与利尿剂用于节律规则的心力衰竭，特别提及心脏病病因分类的重要性
J Clin Invest. 1927 Feb;3(3):521-39. doi: 10.1172/JCI100098.
3
Therapeutic efficacy or oral pirbuterol in severe chronic congestive heart failure: acute hemodynamic and long-term ambulatory evaluation.口服吡布特罗治疗重度慢性充血性心力衰竭的疗效：急性血流动力学及长期动态评估
Am Heart J. 1981 Sep;102(3 Pt 2):555-63. doi: 10.1016/0002-8703(81)90744-4.
4
Long-term amrinone therapy in patients with severe heart failure: drug-dependent hemodynamic benefits despite progression of disease.重度心力衰竭患者的长期氨力农治疗：尽管疾病进展，但仍有药物依赖性血流动力学益处。
Am J Med. 1982 Jan;72(1):113-8. doi: 10.1016/0002-9343(82)90597-6.
5
Heart failure in outpatients: a randomized trial of digoxin versus placebo.门诊患者的心力衰竭：地高辛与安慰剂的随机试验。
N Engl J Med. 1982 Mar 25;306(12):699-705. doi: 10.1056/NEJM198203253061202.
6
Evaluation of a new bipyridine inotropic agent--milrinone--in patients with severe congestive heart failure.新型双吡啶类强心剂米力农用于重症充血性心力衰竭患者的评估。
N Engl J Med. 1983 Sep 29;309(13):748-56. doi: 10.1056/NEJM198309293091302.
7
Long-term therapy with a new cardiotonic agent, WIN 47203: drug-dependent improvement in cardiac performance and progression of the underlying disease.新型强心剂WIN 47203的长期治疗：心脏功能的药物依赖性改善及基础疾病的进展
J Am Coll Cardiol. 1983 Aug;2(2):327-31. doi: 10.1016/s0735-1097(83)80170-3.
8
Effects of discontinuing maintenance digoxin therapy in patients with ischemic heart disease and congestive heart failure in sinus rhythm.窦性心律的缺血性心脏病和充血性心力衰竭患者停用维持性地高辛治疗的效果
Am J Cardiol. 1983 May 1;51(8):1243-50. doi: 10.1016/0002-9149(83)90293-x.
9
Sustained hemodynamic and clinical effects of a new cardiotonic agent, WIN 47203, in patients with severe congestive heart failure.新型强心剂WIN 47203对重度充血性心力衰竭患者的持续血流动力学及临床疗效
Circulation. 1983 May;67(5):1065-70. doi: 10.1161/01.cir.67.5.1065.
10
Dobutamine in heart failure.心力衰竭中的多巴酚丁胺。
Eur Heart J. 1982 Dec;3 Suppl D:107-14.
Zotero 插件